 |
|
Association Between Serum 25-Hydroxyvitamin D Level and Upper Respiratory Tract Infection in the Third National Health and Nutrition Examination Survey
Adit A. Ginde, MD, MPH;
Jonathan M. Mansbach, MD;
Carlos A. Camargo Jr, MD, DrPH
Arch Intern Med. 2009;169(4):384-390.
Background Recent studies suggest a role for vitamin D in innate immunity, including the prevention of respiratory tract infections (RTIs). We hypothesize that serum 25-hydroxyvitamin D (25[OH]D) levels are inversely associated with self-reported recent upper RTI (URTI).
Methods We performed a secondary analysis of the Third National Health and Nutrition Examination Survey, a probability survey of the US population conducted between 1988 and 1994. We examined the association between 25(OH)D level and recent URTI in 18 883 participants 12 years and older. The analysis adjusted for demographics and clinical factors (season, body mass index, smoking history, asthma, and chronic obstructive pulmonary disease).
Results The median serum 25(OH)D level was 29 ng/mL (to convert to nanomoles per liter, multiply by 2.496) (interquartile range, 21-37 ng/mL), and 19% (95% confidence interval [CI], 18%-20%) of participants reported a recent URTI. Recent URTI was reported by 24% of participants with 25(OH)D levels less than 10 ng/mL, by 20% with levels of 10 to less than 30 ng/mL, and by 17% with levels of 30 ng/mL or more (P < .001). Even after adjusting for demographic and clinical characteristics, lower 25(OH)D levels were independently associated with recent URTI (compared with 25[OH]D levels of  30 ng/mL: odds ratio [OR], 1.36; 95% CI, 1.01-1.84 for <10 ng/mL and 1.24; 1.07-1.43 for 10 to <30 ng/mL). The association between 25(OH)D level and URTI seemed to be stronger in individuals with asthma and chronic obstructive pulmonary disease (OR, 5.67 and 2.26, respectively).
Conclusions Serum 25(OH)D levels are inversely associated with recent URTI. This association may be stronger in those with respiratory tract diseases. Randomized controlled trials are warranted to explore the effects of vitamin D supplementation on RTI.
Author Affiliations: Department of Emergency Medicine, University of Colorado Denver School of Medicine, Aurora (Dr Ginde); and Department of Medicine, Children's Hospital Boston (Dr Mansbach), and Department of Emergency Medicine, Massachusetts General Hospital (Dr Camargo), Harvard Medical School, Boston.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Vitamin D Level, Respiratory Tract Infections, and Controlled Trials
Harri Hemilä
Arch Intern Med. 2009;169(15):1443.
EXTRACT
| FULL TEXT
Vitamin D Level, Respiratory Tract Infections, and Controlled Trials—Reply
Adit A. Ginde, Jonathan M. Mansbach, and Carlos A. Camargo, Jr
Arch Intern Med. 2009;169(15):1443-1444.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Update in Vitamin D
Adams and Hewison
J. Clin. Endocrinol. Metab. 2010;95:471-478.
ABSTRACT
| FULL TEXT
Vitamin D Decreases Respiratory Syncytial Virus Induction of NF-{kappa}B-Linked Chemokines and Cytokines in Airway Epithelium While Maintaining the Antiviral State
Hansdottir et al.
J. Immunol. 2010;184:965-974.
ABSTRACT
| FULL TEXT
Review: oral vitamin D prevents non-vertebral and hip fractures in a dose-dependent manner in patients >=65 years of age
Denman
Evid. Based Med. 2009;14:149-149.
FULL TEXT
CAM and Respiratory Disease
Sorkness
Nutr Clin Pract 2009;24:609-615.
ABSTRACT
| FULL TEXT
Vitamin D Level, Respiratory Tract Infections, and Controlled Trials
Hemila
Arch Intern Med 2009;169:1443-1443.
FULL TEXT
Vitamin D Level, Respiratory Tract Infections, and Controlled Trials--Reply
Ginde et al.
Arch Intern Med 2009;169:1443-1444.
FULL TEXT
|
